Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Graham McIlroy

Showing results (21-30 of 37) with videos related to

Pageof 4
Sort By:
Plos Genetics|August 29, 2017
Kek-6: A truncated-Trk-like receptor for Drosophila neurotrophin 2 regulates structural synaptic plasticitySuzana Ulian-Benitez, Simon Bishop, Istvan Foldi, et al.
Cell Transplantation|August 19, 2020
Autoimmune Cytopenias Developing Late Post Alemtuzumab-Based Allogeneic Stem Cell Transplantation: Presentation of Short Case Series from a Transplant CenterRebecca Lloyd, Emmanouil Nikolousis, Bhuvan Kishore, et al.
BMC Cancer|March 26, 2024
Investigator choice of standard therapy versus sequential novel therapy arms in the treatment of relapsed follicular lymphoma (REFRACT): study protocol for a multi-centre, open-label, randomised, phase II platform trialGraham McIlroy, Siân Lax, Charlotte Gaskell, et al.
The Lancet. Haematology|December 15, 2021
Ponatinib with fludarabine, cytarabine, idarubicin, and granulocyte colony-stimulating factor chemotherapy for patients with blast-phase chronic myeloid leukaemia (MATCHPOINT): a single-arm, multicentre, phase 1/2 trialMhairi Copland, Daniel Slade, Graham McIlroy, et al.
British Journal of Haematology|March 11, 2026
Haematopoietic stem cell transplantation outcomes for teenage and young adult patients with acute leukaemia: A British Society of Blood and Marrow Transplantation and Cellular Therapy registry studyGraham McIlroy, Ben Carpenter, Rachael Hough, et al.
British Journal of Haematology|May 26, 2025
Monoclonal immunoglobulin measurement by mass spectrometry in patients with multiple myeloma and kidney failure: Analysis from the EuLITE trialGraham McIlroy, Hannah V Giles, Amy Rollins, et al.
Blood Advances|September 12, 2025
mTOR activity and metabolic reprogramming of CD8+ T cells is impaired under hypoxia and within the multiple myeloma bone marrowTaylor Fulton-Ward, Nancy Gudgeon, Isaac Thirlwell, et al.
Leukemia Research|July 6, 2019
Very early lineage-specific chimerism after reduced intensity stem cell transplantation is highly predictive of clinical outcome for patients with myeloid diseaseFrancesca A M Kinsella, Charlotte F Inman, Amy Gudger, et al.
The Journal of Infection|September 3, 2023
Robust generation of neutralising antibodies against Omicron variants following bivalent mRNA booster vaccine in elderly people aged >80 yearsHelen Parry, Rachel Bruton, Grace Uwenedi, et al.
Blood Cancer Journal|January 25, 2024
Enhancement of Omicron-specific immune responses following bivalent COVID-19 booster vaccination in patients with chronic lymphocytic leukaemiaThomas Roberts, Grace Uwenedi, Rachel Bruton, et al.
Pageof 4

Showing results (21-30 of 37) with videos related to

Sort By:
Pageof 4
Plos Genetics|August 29, 2017
Kek-6: A truncated-Trk-like receptor for Drosophila neurotrophin 2 regulates structural synaptic plasticitySuzana Ulian-Benitez, Simon Bishop, Istvan Foldi, et al.
Cell Transplantation|August 19, 2020
Autoimmune Cytopenias Developing Late Post Alemtuzumab-Based Allogeneic Stem Cell Transplantation: Presentation of Short Case Series from a Transplant CenterRebecca Lloyd, Emmanouil Nikolousis, Bhuvan Kishore, et al.
BMC Cancer|March 26, 2024
Investigator choice of standard therapy versus sequential novel therapy arms in the treatment of relapsed follicular lymphoma (REFRACT): study protocol for a multi-centre, open-label, randomised, phase II platform trialGraham McIlroy, Siân Lax, Charlotte Gaskell, et al.
The Lancet. Haematology|December 15, 2021
Ponatinib with fludarabine, cytarabine, idarubicin, and granulocyte colony-stimulating factor chemotherapy for patients with blast-phase chronic myeloid leukaemia (MATCHPOINT): a single-arm, multicentre, phase 1/2 trialMhairi Copland, Daniel Slade, Graham McIlroy, et al.
British Journal of Haematology|March 11, 2026
Haematopoietic stem cell transplantation outcomes for teenage and young adult patients with acute leukaemia: A British Society of Blood and Marrow Transplantation and Cellular Therapy registry studyGraham McIlroy, Ben Carpenter, Rachael Hough, et al.
British Journal of Haematology|May 26, 2025
Monoclonal immunoglobulin measurement by mass spectrometry in patients with multiple myeloma and kidney failure: Analysis from the EuLITE trialGraham McIlroy, Hannah V Giles, Amy Rollins, et al.
Blood Advances|September 12, 2025
mTOR activity and metabolic reprogramming of CD8+ T cells is impaired under hypoxia and within the multiple myeloma bone marrowTaylor Fulton-Ward, Nancy Gudgeon, Isaac Thirlwell, et al.
Leukemia Research|July 6, 2019
Very early lineage-specific chimerism after reduced intensity stem cell transplantation is highly predictive of clinical outcome for patients with myeloid diseaseFrancesca A M Kinsella, Charlotte F Inman, Amy Gudger, et al.
The Journal of Infection|September 3, 2023
Robust generation of neutralising antibodies against Omicron variants following bivalent mRNA booster vaccine in elderly people aged >80 yearsHelen Parry, Rachel Bruton, Grace Uwenedi, et al.
Blood Cancer Journal|January 25, 2024
Enhancement of Omicron-specific immune responses following bivalent COVID-19 booster vaccination in patients with chronic lymphocytic leukaemiaThomas Roberts, Grace Uwenedi, Rachel Bruton, et al.
Pageof 4